OB

OH Beteiligungen

Europe, Baden-Wurttemberg, Germany, Baden

Description

OH Beteiligungen is a German-based venture capital firm specialized in early stage investments.

Investor Profile

OH Beteiligungen has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OH Beteiligungen frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 1
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
Swisscom Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
DH Capital
North America, New York, United States, New York
Co-Investments: 3
NTEC
Asia, Al Kuwayt, Kuwait, Kuwait
Co-Investments: 1

What are some of recent deals done by OH Beteiligungen?

immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Series BFeb 8, 2007
Amount Raised: $52,113,801
CureVac

Tübingen, Baden-Wurttemberg, Germany

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

BiopharmaBiotechnologyTherapeutics
Series BJan 18, 2006
Amount Raised: $26,622,715
CureVac

Tübingen, Baden-Wurttemberg, Germany

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

BiopharmaBiotechnologyTherapeutics
Series AJan 1, 2003
Amount Raised: $2,834,467